Selenium Nanoparticles Induce Potent Protective Immune Responses against Vibrio cholerae WC Vaccine in a Mouse Model

Table 1

Formulation of suspension for each group of mice.

Group	Suspension received
WC+Nal	250 μl of PBS containing inactivated Vibrio cholerae (10^8 CFU) and naloxone (0.15 mg)
WC+Se NPs	250 μl of PBS containing inactivated Vibrio cholerae (10^8 CFU) and selenium NPs (100 μg)
WC+diet of Se NPs	250 μl of PBS of inactivated Vibrio cholerae (10^8 CFU), daily diet of Se NPs (100 μg)
WC+Nal+Se NPs	250 μl of PBS containing inactivated Vibrio cholerae (10^8 CFU) and naloxone (0.15 mg) and selenium NPs (100 μg)
WC+Nal+diet of Se NPs	250 μl of PBS containing inactivated Vibrio cholerae (10^8 CFU) and naloxone (0.15 mg), daily diet of Se NPs (100 μg)
Dukoral vaccine	200 μl of PBS containing Dukoral vaccine (10^8 CFU)
Control	250 μl of inactivated Vibrio cholerae (10^8 CFU)
Control	250 μl of PBS